药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Orciprenaline
Pitolisant
The risk or severity of adverse effects can be increased when Pitolisant is combined with Tubocurarine.
Orciprenaline
Dexchlorpheniramine maleate
The risk or severity of adverse effects can be increased when Dexchlorpheniramine maleate is combined with Tubocurarine.
Orciprenaline
Palbociclib
The risk or severity of adverse effects can be increased when Palbociclib is combined with Tubocurarine.
Orciprenaline
Linagliptin
The risk or severity of adverse effects can be increased when Linagliptin is combined with Tubocurarine.
Orciprenaline
Saquinavir
The risk or severity of adverse effects can be increased when Saquinavir is combined with Tubocurarine.
Orciprenaline
Pirlimycin
The risk or severity of neuromuscular blockade can be increased when Pirlimycin is combined with Tubocurarine.
Orciprenaline
Cannabinol
The risk or severity of adverse effects can be increased when Cannabinol is combined with Tubocurarine.
Orciprenaline
Palmidrol
The risk or severity of adverse effects can be increased when Palmidrol is combined with Tubocurarine.
Orciprenaline
Nabiximols
The risk or severity of adverse effects can be increased when Nabiximols is combined with Tubocurarine.
Orciprenaline
WIN 55212-2
The risk or severity of adverse effects can be increased when WIN 55212-2 is combined with Tubocurarine.
Orciprenaline
Surinabant
The risk or severity of adverse effects can be increased when Surinabant is combined with Tubocurarine.
Orciprenaline
Ibipinabant
The risk or severity of adverse effects can be increased when Ibipinabant is combined with Tubocurarine.
Orciprenaline
Ajulemic acid
The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Tubocurarine.
Orciprenaline
GW842166
The risk or severity of adverse effects can be increased when GW842166 is combined with Tubocurarine.
Orciprenaline
Cannabidiol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tubocurarine.
Orciprenaline
Taranabant
The risk or severity of adverse effects can be increased when Taranabant is combined with Tubocurarine.
Orciprenaline
Rimonabant
The risk or severity of adverse effects can be increased when Rimonabant is combined with Tubocurarine.
Orciprenaline
SLV319
The risk or severity of adverse effects can be increased when SLV319 is combined with Tubocurarine.
Orciprenaline
Naxitamab
Tubocurarine may increase the neurotoxic activities of Naxitamab.
Orciprenaline
Polymyxin B
Tubocurarine may increase the neurotoxic activities of Polymyxin B.